ENDEFR
Home › Belgium › SKELETAL CELL THERAPY SUPPORT

SKELETAL CELL THERAPY SUPPORT

Naamloze vennootschap (NV) · CHARLEROI, Belgium · LEI 549300AMMNSV1RPRXX43
LEI lapsed

Summary

SKELETAL CELL THERAPY SUPPORT is registered in Belgium and entered in the “Crossroads Bank for Enterprises (KBO/BCE)” under number 0841.570.812. Its legal form is Naamloze vennootschap (NV) – public limited company (Belgium). According to GLEIF, its ultimate parent is BioSenic (Belgium), which is also its direct parent. That group has 1 subsidiary with LEIs in 1 country, 1 of them in Belgium. The LEI was first issued on 3 Apr 2020 and the record was last updated on 31 Jul 2023. It has lapsed: renewal was due by 1 Apr 2021. AssetCensus found 3 data-quality notes for this entity (see below).

Written from GLEIF data using fixed, reviewed sentence templates.

Data-quality notes (AssetCensus analysis)

  • The LEI has lapsed: it was due for renewal by 1 Apr 2021 and was not renewed, so GLEIF's data for this entity has not been re-verified since. A lapsed LEI does not mean the company has ceased to exist.
  • The ultimate-parent link rests on accounts for the period ending 31 Dec 2019, more than 24 months before this data release. The group may have changed since.
  • The ultimate-parent relationship record was not renewed; it was last updated on 31 Jul 2023.

Company details

Legal formNaamloze vennootschap (NV)
public limited company (Belgium)
RegisterCrossroads Bank for Enterprises (KBO/BCE) · Register website
Registration number0841.570.812
Registration authorityFederal Public Service Economy (Ministry of Economy)
JurisdictionBelgium
Registered addressRUE AUGUSTE PICCARD 37, GOSSELIES, 6041 CHARLEROI, Belgium
Headquarters address37 RUE AUGUSTE PICCARD, 6041 CHARLEROI, Belgium
Categorycompany or other legal entity
Statusactive
LEI549300AMMNSV1RPRXX43
LEI statuslapsed
LEI first issued3 Apr 2020
LEI record last updated31 Jul 2023
Next LEI renewal1 Apr 2021
Corroboration of the LEI recordfully corroborated

Group membership

BioSenic Belgium ultimate parent
SKELETAL CELL THERAPY SUPPORT this entity

Relationship to the parent

Direct parentUltimate parent
ParentBioSenicBioSenic
Accounting period1 Jan 2019 to 31 Dec 20191 Jan 2019 to 31 Dec 2019
Evidencesupporting documentssupporting documents
Corroborationsupplied by the entity onlysupplied by the entity only
Relationship start1 Apr 20201 Apr 2020
Recorded at GLEIF since3 Apr 20203 Apr 2020
Last updated31 Jul 202331 Jul 2023
Record statusnot renewednot renewed